Sectors
RNXT
RenovoRx, Inc.
1.89
2 x 1.76
4 x 1.89
bid
ask
+
0.22
13.17%
02:09 PM
timesize
| Ytd | 125.00% | |
| 1y | 96.88% |
1.65
day range
1.92
0.70
52 week range
1.92
| Open | 1.72 | Prev Close | 1.67 | Low | 1.65 | High | 1.92 | Mkt Cap | 84.39M |
| Vol | 2.33M | Avg Vol | 357.87K | EPS | -0.31 | P/E | N/A | Forward P/E | -3.10 |
| Beta | 0.99 | Short Ratio | 3.43 | Inst. Own | 8.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.05 | 200-d Avg | 0.96 | 1yr Est | 5.50 |
| Income Statement | |||
| Total Revenue | 909.00K | ||
| Revenues (USD) | 909.00K | ||
| Cost of Revenue | 143.00K | ||
| Gross Profit | 766.00K | ||
| Operating Expenses | 4.12M | ||
| Research and Development Expense | 1.20M | ||
| Selling, General and Administrative Expense | 2.92M | ||
| Operating Income | -3.35M | ||
| Net Income | -2.91M | ||
| Net Income Common Stock | -2.91M | ||
| Net Income Common Stock (USD) | -2.91M | ||
| Consolidated Income | -2.91M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -2.91M | ||
| Earning Before Interest & Taxes (USD) | -2.91M | ||
| Weighted Average Shares | 47.30M | ||
| Weighted Average Shares Diluted | 47.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.48M | ||
| Cash and Equivalents (USD) | 9.48M | ||
| Trade and Non-Trade Receivables | 480.00K | ||
| Current Assets | 10.81M | ||
| Property, Plant & Equipment Net | 462.00K | ||
| Total Assets | 11.47M | ||
| Total Debt | 259.00K | ||
| Current Liabilities | 1.88M | ||
| Debt Non-Current | 259.00K | ||
| Total Liabilities | 2.49M | ||
| Accumulated Retained Earnings (Deficit) | -67.82M | ||
| Shareholders Equity | 8.98M | ||
| Shareholders Equity (USD) | 8.98M | ||
| Assets Non-Current | 662.00K | ||
| Total Debt (USD) | 259.00K | ||
| Inventory | 383.00K | ||
| Liabilities Non-Current | 609.00K | ||
| Trade and Non-Trade Payables | 866.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 39.00K | ||
| Net Cash Flow from Financing | 55.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.88M | ||
| Capital Expenditure | -71.00K | ||
| Issuance (Purchase) of Equity Shares | 55.00K | ||
| Net Cash Flow from Investing | -71.00K | ||
| Net Cash Flow from Operations | -2.87M | ||
| Share Based Compensation | 570.00K | ||